Deborah C. Mash

50.6k total citations · 2 hit papers
234 papers, 16.5k citations indexed

About

Deborah C. Mash is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Deborah C. Mash has authored 234 papers receiving a total of 16.5k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Cellular and Molecular Neuroscience, 106 papers in Molecular Biology and 57 papers in Neurology. Recurrent topics in Deborah C. Mash's work include Neurotransmitter Receptor Influence on Behavior (70 papers), Neuroscience and Neuropharmacology Research (55 papers) and Receptor Mechanisms and Signaling (48 papers). Deborah C. Mash is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (70 papers), Neuroscience and Neuropharmacology Research (55 papers) and Receptor Mechanisms and Signaling (48 papers). Deborah C. Mash collaborates with scholars based in United States, Canada and United Kingdom. Deborah C. Mash's co-authors include Donna D. Flynn, Julie K. Staley, Lincoln T. Potter, John Pablo, Sandra Weıntraub, William Lee Hearn, Marsel Mesulam, Spiridon Papapetropoulos, Allan I. Levey and Pamela L Shaw and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Deborah C. Mash

233 papers receiving 16.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dynamics of Hippocampal Neurogenesis in Adult Humans

2013 1.3k citations Deborah C. Mash et al. profile →
Loss of M2 Muscarine Receptors in the Cerebral Cortex in Alzheimer's Disease and Experimental Cholinergic Denervation

1985 597 citations Deborah C. Mash, Donna D. Flynn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah C. Mash United States	71	7.5k	6.1k	2.9k	2.7k	2.0k	234	16.5k
Harry W.M. Steinbusch Netherlands	76	9.9k 1.3×	7.3k 1.2×	2.3k 0.8×	4.6k 1.7×	3.1k 1.5×	388	22.8k
Jean Lud Cadet United States	71	9.4k 1.2×	5.4k 0.9×	1.6k 0.6×	1.9k 0.7×	2.2k 1.1×	359	17.5k
Per Svenningsson Sweden	76	9.0k 1.2×	8.3k 1.4×	4.6k 1.6×	2.0k 0.8×	2.0k 1.0×	453	20.2k
Giuseppe Battaglia Italy	63	7.8k 1.0×	4.9k 0.8×	1.9k 0.6×	1.8k 0.7×	938 0.5×	325	13.3k
Stephen J. Kish Canada	73	9.5k 1.3×	5.6k 0.9×	6.3k 2.2×	2.2k 0.8×	1.7k 0.8×	284	17.9k
Gavin P. Reynolds United Kingdom	72	7.7k 1.0×	5.0k 0.8×	2.6k 0.9×	2.7k 1.0×	2.4k 1.2×	329	16.7k
Peter R. Schofield Australia	74	8.3k 1.1×	9.8k 1.6×	1.2k 0.4×	2.5k 0.9×	1.8k 0.9×	343	20.6k
Giorgio Racagni Italy	67	8.0k 1.1×	4.7k 0.8×	866 0.3×	2.0k 0.7×	1.7k 0.8×	363	16.4k
Irwin Lucki United States	71	10.4k 1.4×	5.2k 0.8×	850 0.3×	2.3k 0.9×	2.1k 1.0×	210	19.6k
Akira Sawa United States	73	5.2k 0.7×	10.8k 1.8×	1.4k 0.5×	2.2k 0.8×	2.2k 1.1×	325	20.4k

Countries citing papers authored by Deborah C. Mash

Since Specialization

Citations

This map shows the geographic impact of Deborah C. Mash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah C. Mash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah C. Mash more than expected).

Fields of papers citing papers by Deborah C. Mash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah C. Mash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah C. Mash. The network helps show where Deborah C. Mash may publish in the future.

Co-authorship network of co-authors of Deborah C. Mash

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah C. Mash. A scholar is included among the top collaborators of Deborah C. Mash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah C. Mash. Deborah C. Mash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maitra, Malosree, Reza Rahimian, Jennie Yang, et al.. (2023). Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes. Nature Communications. 14(1). 2912–2912. 62 indexed citations

Corradin, Olivia, Richard Sallari, Bibi Kassim, et al.. (2022). Convergence of case-specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose. Molecular Psychiatry. 27(4). 2158–2170. 7 indexed citations

Siminoff, Laura A., Deborah C. Mash, Maureen Wilson-Genderson, et al.. (2021). Making a family decision to donate the brain for genomic research: lessons from the genotype-tissue expression project (GTEx). Cell and Tissue Banking. 22(3). 431–441. 4 indexed citations

Xing, Jie, et al.. (2018). Species and cell-type properties of classically defined human and rodent neurons and glia. eLife. 7. 62 indexed citations

Luo, Chongyuan, Angeline Rivkin, Jingtian Zhou, et al.. (2018). Robust single-cell DNA methylome profiling with snmC-seq2. Nature Communications. 9(1). 3824–3824. 101 indexed citations

Chen, Jia, Raphael M. Bendriem, Charles E. Spivak, et al.. (2016). CYP3A5 Mediates Effects of Cocaine on Human Neocorticogenesis: Studies using an In Vitro 3D Self-Organized hPSC Model with a Single Cortex-Like Unit. Neuropsychopharmacology. 42(3). 774–784. 75 indexed citations

Goldstein, David S., Courtney Holmes, Patti Sullivan, et al.. (2015). Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration. Parkinsonism & Related Disorders. 21(9). 1013–1022. 27 indexed citations

Kohli, Martin, et al.. (2015). Alzheimer disease (AD) specific transcription, DNA methylation and splicing in twenty AD associated loci. Molecular and Cellular Neuroscience. 67. 37–45. 35 indexed citations

Vaccari, Juan Pablo de Rivero, et al.. (2012). Role of RIG-1 signaling in the Pathogenesis of Alzheimer’s Disease (172.1). The Journal of Immunology. 188(1_Supplement). 172.1–172.1. 1 indexed citations

10.

Goldstein, David S., Patti Sullivan, Courtney Holmes, et al.. (2010). Catechols in post-mortem brain of patients with Parkinson disease. European Journal of Neurology. 18(5). 703–710. 111 indexed citations

11.

Bradley, Walter G. & Deborah C. Mash. (2009). Beyond Guam: The cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotrophic Lateral Sclerosis. 10(sup2). 7–20. 145 indexed citations

12.

Mash, Deborah C., Nikhil Adi, Linda Duque, et al.. (2007). Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers. Drug and Alcohol Dependence. 94(1-3). 246–250. 26 indexed citations

13.

Lincoln, Sarah, Owen A. Ross, Nicole M. Milkovic, et al.. (2007). Quantitative PCR-based screening of α-synuclein multiplication in multiple system atrophy. Parkinsonism & Related Disorders. 13(6). 340–342. 24 indexed citations

14.

Tang, Wenxue, et al.. (2003). Molecular profiling of midbrain dopamine regions in cocaine overdose victims. Journal of Neurochemistry. 85(4). 911–924. 85 indexed citations

15.

Hurley, Michael J., Deborah C. Mash, & P. Jenner. (2003). Expression of cannabinoid CB 1 receptor mRNA in basal ganglia of normal and parkinsonian human brain. Journal of Neural Transmission. 110(11). 1279–1288. 82 indexed citations

16.

Haracz, John L., Deborah C. Mash, & Ratna Sircar. (1999). A Multicomponent Learning Model of Drug Abuse: Drug Taking and Craving May Involve Separate Brain Circuits Underlying Instrumental and Classical Conditioning, Respectively. Annals of the New York Academy of Sciences. 877(1). 811–819. 3 indexed citations

17.

Staley, Julie K., et al.. (1996). Vesicular monoamine transporter immunoreactivity is reduced in Parkinsons diseased striatum. The Society for Neuroscience Abstracts. 22. 225. 1 indexed citations

18.

Baumann, Michael H., Deborah C. Mash, & Julie K. Staley. (1995). The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain. Neuroreport. 6(16). 2150–2152. 43 indexed citations

19.

Flynn, Donna D., et al.. (1995). Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: Implications for cholinergic-based therapies. Life Sciences. 56(11-12). 869–876. 57 indexed citations

20.

Mash, Deborah C., Karam F. A. Soliman, & Charles A. Walker. (1981). The effect of altered-hydroxytryptamine levels on beta endorphin content in rat brain. Federation Proceedings. 40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact